Gene expression differences in mice divergently selected for methamphetamine sensitivity

Abraham A. Palmer, Miguel Verbitsky, Rathi Suresh, Helen M. Kamens, Cheryl L. Reed, Na Li, Sue Burkhart-Kasch, Carrie S. McKinnon, John Belknap, T. Conrad Gilliam, Tamara Phillips

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

In an effort to identify genes that may be important for drug-abuse liability, we mapped behavioral quantitative trait loci (bQTL) for sensitivity to the locomotor stimulant effect of methamphetamine (MA) using two mouse lines that were selectively bred for high MA-induced activity (HMACT) or low MA-induced activity (LMACT). We then examined gene expression differences between these lines in the nucleus accumbens, using 20 U74Av2 Affymetrix microarrays and quantitative polymerase chain reaction (qPCR). Expression differences were detected for several genes, including Casein Kinase 1 Epsilon (Csnkle), glutamate receptor, ionotropic, AMPA1 (GluR1), GABA B1 receptor (Gabbr1), and dopamine- and cAMP-regulated phosphoprotein of 32 kDa (Darpp-32). We used the www.WebQTL.org database to identify QTL that regulate the expression of the genes identified by the microarrays (expression QTL; eQTL). This approach identified an eQTL for Csnkle on Chromosome 15 (LOD=3.8) that comapped with a bQTL for the MA stimulation phenotype (LOD=4.5), suggesting that a single allele may cause both traits. The chromosomal region containing this QTL has previously been associated with sensitivity to the stimulant effects of cocaine. These results suggest that selection was associated with (and likely caused) altered gene expression that is partially attributable to different frequencies of gene expression polymorphisms. Combining classical genetics with analysis of whole-genome gene expression and bioinformatic resources provides a powerful method for provisionally identifying genes that influence complex traits. The identified genes provide excellent candidates for future hypothesis-driven studies, translational genetic studies, and pharmacological interventions.

Original languageEnglish (US)
Pages (from-to)291-305
Number of pages15
JournalMammalian Genome
Volume16
Issue number5
DOIs
StatePublished - May 2005

Fingerprint

Methamphetamine
Gene Expression
Quantitative Trait Loci
Casein Kinase Iepsilon
Genes
Dopamine and cAMP-Regulated Phosphoprotein 32
Ionotropic Glutamate Receptors
Chromosomes, Human, Pair 15
GABA Receptors
Nucleus Accumbens
Computational Biology
Cocaine
Substance-Related Disorders
Alleles
Genome
Databases
Pharmacology
Phenotype
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Genetics

Cite this

Gene expression differences in mice divergently selected for methamphetamine sensitivity. / Palmer, Abraham A.; Verbitsky, Miguel; Suresh, Rathi; Kamens, Helen M.; Reed, Cheryl L.; Li, Na; Burkhart-Kasch, Sue; McKinnon, Carrie S.; Belknap, John; Gilliam, T. Conrad; Phillips, Tamara.

In: Mammalian Genome, Vol. 16, No. 5, 05.2005, p. 291-305.

Research output: Contribution to journalArticle

Palmer, AA, Verbitsky, M, Suresh, R, Kamens, HM, Reed, CL, Li, N, Burkhart-Kasch, S, McKinnon, CS, Belknap, J, Gilliam, TC & Phillips, T 2005, 'Gene expression differences in mice divergently selected for methamphetamine sensitivity', Mammalian Genome, vol. 16, no. 5, pp. 291-305. https://doi.org/10.1007/s00335-004-2451-8
Palmer, Abraham A. ; Verbitsky, Miguel ; Suresh, Rathi ; Kamens, Helen M. ; Reed, Cheryl L. ; Li, Na ; Burkhart-Kasch, Sue ; McKinnon, Carrie S. ; Belknap, John ; Gilliam, T. Conrad ; Phillips, Tamara. / Gene expression differences in mice divergently selected for methamphetamine sensitivity. In: Mammalian Genome. 2005 ; Vol. 16, No. 5. pp. 291-305.
@article{875150e19454474da5af93ab41d21cea,
title = "Gene expression differences in mice divergently selected for methamphetamine sensitivity",
abstract = "In an effort to identify genes that may be important for drug-abuse liability, we mapped behavioral quantitative trait loci (bQTL) for sensitivity to the locomotor stimulant effect of methamphetamine (MA) using two mouse lines that were selectively bred for high MA-induced activity (HMACT) or low MA-induced activity (LMACT). We then examined gene expression differences between these lines in the nucleus accumbens, using 20 U74Av2 Affymetrix microarrays and quantitative polymerase chain reaction (qPCR). Expression differences were detected for several genes, including Casein Kinase 1 Epsilon (Csnkle), glutamate receptor, ionotropic, AMPA1 (GluR1), GABA B1 receptor (Gabbr1), and dopamine- and cAMP-regulated phosphoprotein of 32 kDa (Darpp-32). We used the www.WebQTL.org database to identify QTL that regulate the expression of the genes identified by the microarrays (expression QTL; eQTL). This approach identified an eQTL for Csnkle on Chromosome 15 (LOD=3.8) that comapped with a bQTL for the MA stimulation phenotype (LOD=4.5), suggesting that a single allele may cause both traits. The chromosomal region containing this QTL has previously been associated with sensitivity to the stimulant effects of cocaine. These results suggest that selection was associated with (and likely caused) altered gene expression that is partially attributable to different frequencies of gene expression polymorphisms. Combining classical genetics with analysis of whole-genome gene expression and bioinformatic resources provides a powerful method for provisionally identifying genes that influence complex traits. The identified genes provide excellent candidates for future hypothesis-driven studies, translational genetic studies, and pharmacological interventions.",
author = "Palmer, {Abraham A.} and Miguel Verbitsky and Rathi Suresh and Kamens, {Helen M.} and Reed, {Cheryl L.} and Na Li and Sue Burkhart-Kasch and McKinnon, {Carrie S.} and John Belknap and Gilliam, {T. Conrad} and Tamara Phillips",
year = "2005",
month = "5",
doi = "10.1007/s00335-004-2451-8",
language = "English (US)",
volume = "16",
pages = "291--305",
journal = "Mammalian Genome",
issn = "0938-8990",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Gene expression differences in mice divergently selected for methamphetamine sensitivity

AU - Palmer, Abraham A.

AU - Verbitsky, Miguel

AU - Suresh, Rathi

AU - Kamens, Helen M.

AU - Reed, Cheryl L.

AU - Li, Na

AU - Burkhart-Kasch, Sue

AU - McKinnon, Carrie S.

AU - Belknap, John

AU - Gilliam, T. Conrad

AU - Phillips, Tamara

PY - 2005/5

Y1 - 2005/5

N2 - In an effort to identify genes that may be important for drug-abuse liability, we mapped behavioral quantitative trait loci (bQTL) for sensitivity to the locomotor stimulant effect of methamphetamine (MA) using two mouse lines that were selectively bred for high MA-induced activity (HMACT) or low MA-induced activity (LMACT). We then examined gene expression differences between these lines in the nucleus accumbens, using 20 U74Av2 Affymetrix microarrays and quantitative polymerase chain reaction (qPCR). Expression differences were detected for several genes, including Casein Kinase 1 Epsilon (Csnkle), glutamate receptor, ionotropic, AMPA1 (GluR1), GABA B1 receptor (Gabbr1), and dopamine- and cAMP-regulated phosphoprotein of 32 kDa (Darpp-32). We used the www.WebQTL.org database to identify QTL that regulate the expression of the genes identified by the microarrays (expression QTL; eQTL). This approach identified an eQTL for Csnkle on Chromosome 15 (LOD=3.8) that comapped with a bQTL for the MA stimulation phenotype (LOD=4.5), suggesting that a single allele may cause both traits. The chromosomal region containing this QTL has previously been associated with sensitivity to the stimulant effects of cocaine. These results suggest that selection was associated with (and likely caused) altered gene expression that is partially attributable to different frequencies of gene expression polymorphisms. Combining classical genetics with analysis of whole-genome gene expression and bioinformatic resources provides a powerful method for provisionally identifying genes that influence complex traits. The identified genes provide excellent candidates for future hypothesis-driven studies, translational genetic studies, and pharmacological interventions.

AB - In an effort to identify genes that may be important for drug-abuse liability, we mapped behavioral quantitative trait loci (bQTL) for sensitivity to the locomotor stimulant effect of methamphetamine (MA) using two mouse lines that were selectively bred for high MA-induced activity (HMACT) or low MA-induced activity (LMACT). We then examined gene expression differences between these lines in the nucleus accumbens, using 20 U74Av2 Affymetrix microarrays and quantitative polymerase chain reaction (qPCR). Expression differences were detected for several genes, including Casein Kinase 1 Epsilon (Csnkle), glutamate receptor, ionotropic, AMPA1 (GluR1), GABA B1 receptor (Gabbr1), and dopamine- and cAMP-regulated phosphoprotein of 32 kDa (Darpp-32). We used the www.WebQTL.org database to identify QTL that regulate the expression of the genes identified by the microarrays (expression QTL; eQTL). This approach identified an eQTL for Csnkle on Chromosome 15 (LOD=3.8) that comapped with a bQTL for the MA stimulation phenotype (LOD=4.5), suggesting that a single allele may cause both traits. The chromosomal region containing this QTL has previously been associated with sensitivity to the stimulant effects of cocaine. These results suggest that selection was associated with (and likely caused) altered gene expression that is partially attributable to different frequencies of gene expression polymorphisms. Combining classical genetics with analysis of whole-genome gene expression and bioinformatic resources provides a powerful method for provisionally identifying genes that influence complex traits. The identified genes provide excellent candidates for future hypothesis-driven studies, translational genetic studies, and pharmacological interventions.

UR - http://www.scopus.com/inward/record.url?scp=23844553181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23844553181&partnerID=8YFLogxK

U2 - 10.1007/s00335-004-2451-8

DO - 10.1007/s00335-004-2451-8

M3 - Article

C2 - 16104378

AN - SCOPUS:23844553181

VL - 16

SP - 291

EP - 305

JO - Mammalian Genome

JF - Mammalian Genome

SN - 0938-8990

IS - 5

ER -